Cargando…

Protective Role of 4-(4-Hydroxy-3-methoxyphenyl)-2-Butanone on Prostatic Cells Hyperplasia of Rats and Human, 5α-reductase Inhibition Pathway

BACKGROUND: Prostate gland is an exocrine gland that could be affected by various pathological conditions. Benign prostatic hyperplasia (BPH) is an age-dependent medical condition caused by increased activity of 5α-reductase enzyme (5α-R). Medical treatment by finasteride is considered during treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Ahmed S., Soliman, Mohamed Gaber
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751679/ https://www.ncbi.nlm.nih.gov/pubmed/35070691 http://dx.doi.org/10.4103/JMAU.JMAU_37_20

Ejemplares similares

A Review on Pharmacological Properties of Zingerone (4-(4-Hydroxy-3-methoxyphenyl)-2-butanone)
por: Ahmad, Bilal, et al.
Publicado: (2015)

Reactivity of Formaldehyde during 4-Hydroxy-2-butanone Synthesis in Supercritical State
por: Chen, Zhirong, et al.
Publicado: (2022)

The 3-Hydroxy-2-Butanone Pathway Is Required for Pectobacterium carotovorum Pathogenesis
por: Marquez-Villavicencio, Maria del Pilar, et al.
Publicado: (2011)

Pao Pereira Extract Attenuates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by inhibiting 5α-Reductase
por: Liu, Jiakuan, et al.
Publicado: (2019)

4-Hydroxy-5-(4-methoxyphenyl)pyrrolidin-2-one
por: Mohammat, M. Fazli, et al.
Publicado: (2008)

Ethyl 3-(4-hydroxyphenoxy)-2-(4-methoxyphenyl)acrylate
por: Hou, Jin
Publicado: (2008)

Cardiovascular Outcomes of α-Blockers vs 5-α Reductase Inhibitors for Benign Prostatic Hyperplasia
por: Zhang, Jiandong, et al.
Publicado: (2023)

3-Hydroxy-2-(4-methoxyphenyl)-4H-chromen-4-one
por: Wera, Michał, et al.
Publicado: (2011)

5-α reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer
por: Robinson, David, et al.
Publicado: (2015)

(Z)-2-Hydroxy-3-(4-methoxyphenyl)acrylic acid
por: Ouyang, Hui, et al.
Publicado: (2009)

1-(5-Bromo-2-hydroxy-4-methoxyphenyl)ethanone
por: Qing, Wei-Xia, et al.
Publicado: (2009)

9α-Hydroxy-12-{[4-(4-methoxyphenyl)piperazin-1-yl]methyl}-4,8-dimethyl-3,14-dioxatricyclo[9.3.0.0(2,4)]tetradec-7-en-13-one
por: Moumou, Mohamed, et al.
Publicado: (2012)

(Z)-3-Hydroxy-4-(4-methoxyphenyl)but-3-en-2-one
por: Fang, Wei, et al.
Publicado: (2013)

Medical therapy for clinical benign prostatic hyperplasia: α1 Antagonists, 5α reductase inhibitors and their combination
por: Shum, Cheuk Fan, et al.
Publicado: (2017)

Induction of lung lesions in Wistar rats by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its inhibition by aspirin and phenethyl isothiocyanate
por: Ye, Bo, et al.
Publicado: (2007)

4-Hydroxy-6-(4-methoxyphenyl)-4-phenyl-1,3-diazinane-2-thione
por: Devarajegowda, H. C., et al.
Publicado: (2011)

2-Acetamido-3-(4-hydroxy-3-methoxyphenyl)acrylic acid
por: Lan, Xiao-Bing, et al.
Publicado: (2008)

2,2-Dibromo-1-(4-hydroxy-3-methoxyphenyl)ethanone
por: Yang, Xiao-Hui, et al.
Publicado: (2009)

Anilinium 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
por: Zhu, Li-Cai
Publicado: (2010)

Corni Fructus attenuates testosterone-induced benign prostatic hyperplasia by suppressing 5α-reductase and androgen receptor expression in rats
por: Hwangbo, Hyun, et al.
Publicado: (2018)

Raspberry Ketone [4-(4-Hydroxyphenyl)-2-Butanone] Differentially Effects Meal Patterns and Cardiovascular Parameters in Mice
por: Kshatriya, Dushyant, et al.
Publicado: (2020)

10α-Hydroxy-13-{[4-(4-methoxyphenyl)piperazin-1-yl]methyl}-4,9-dimethyl-3,8,15-trioxatetracyclo[10.3.0.0(2,4).0(7,9)]pentadecan-14-one
por: Moumou, Mohamed, et al.
Publicado: (2012)

1-(2-Hydroxy-3,4-dimethoxyphenyl)-2-(4-methoxyphenyl)ethanone
por: Xiao, Zhu-Ping, et al.
Publicado: (2008)

Methyl 5-chloro-2-hydroxy-3-(4-methoxyphenyl)-4,6-dimethylbenzoate
por: Adeel, Muhammad, et al.
Publicado: (2009)

Chrysophanic acid reduces testosterone-induced benign prostatic hyperplasia in rats by suppressing 5α-reductase and extracellular signal-regulated kinase
por: Youn, Dong-Hyun, et al.
Publicado: (2016)

Evidence for the Chemical Mechanism of RibB (3,4-Dihydroxy-2-butanone 4-phosphate Synthase) of Riboflavin Biosynthesis
por: Kenjić, Nikola, et al.
Publicado: (2022)

Discovery of (4-bromophenyl)(3-hydroxy-4-methoxyphenyl)methanone through upregulating hTERT induces cell apoptosis and ERS
por: Cheng, Xiu, et al.
Publicado: (2017)

Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase
por: Choi, Hyun-Myung, et al.
Publicado: (2016)

Effect of Shifting from Combination Therapy to Monotherapy of α-Blockers or 5α-Reductase Inhibitors on Prostate Volume and Symptoms in Patients with Benign Prostatic Hyperplasia
por: Kim, Hyoung Woo, et al.
Publicado: (2011)

Cynanchum wilfordii Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia by Regulating 5α-Reductase and Androgen Receptor Activities in a Rat Model
por: Lee, Gyuok, et al.
Publicado: (2017)

The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia
por: Kim, Eric H., et al.
Publicado: (2018)

Liquid Chromatography–Electrospray Ionization–Tandem Mass Spectrometry Quantitation of Urinary [Pyridine-D(4)]4-hydroxy-4-(3-pyridyl)butanoic Acid, a Biomarker of 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Metabolic Activation in Smokers
por: Jing, Meng, et al.
Publicado: (2014)

2-[Hydroxy(4-methoxyphenyl)methylidene]indane-1,3-dione
por: Gu, Jing-Chi, et al.
Publicado: (2012)

(2-Hydroxy-4-methoxyphenyl)(2-hydroxyphenyl)methanone
por: Betz, Richard, et al.
Publicado: (2011)

(2E)-N-(3,5-Dibromo-4-methoxyphenyl)-2-(hydroxyimino)acetamide
por: Garden, Simon J., et al.
Publicado: (2010)

(E)-N′-[(E)-3-(4-Hydroxy-3-methoxyphenyl)allylidene]isonicotinohydrazide
por: Naveenkumar, H. S., et al.
Publicado: (2010)

Synthesis and bioactivity of oxovanadium(IV)tetra(4-methoxyphenyl)porphyrinsalicylates
por: Bajju, Gauri Devi, et al.
Publicado: (2019)

The crystal structure of 1-(2-hydroxy-5-methoxyphenyl)ethanone 4,4-dimethylthiosemicarbazone
por: Anderson, Brian J., et al.
Publicado: (2015)

A Dual 5α-Reductase Inhibitor Dutasteride Caused Reductions in Vascular Density and Area in Benign Prostatic Hyperplasia
por: Zaitsu, Masayoshi, et al.
Publicado: (2013)

Protective effects of combination of Stauntonia hexaphylla and Cornus officinalis on testosterone-induced benign prostatic hyperplasia through inhibition of 5α- reductase type 2 and induced cell apoptosis
por: Karunasagara, Shanika, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l0ski0996kfic0o154htsln1g1